European phase II study of mogamulizumab, an anti-CCR4...

Haematologica 2016 / 10 Vol. 101; Iss. 10

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D., dAmore, F., Haioun, C., Thieblemont, C., Gonzalez-Barca, E., Garcia, C. G., Johnson, P. W., van Imhoff, G. W.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
101
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2016.146977
Date:
October, 2016
File:
PDF, 558 KB
english, 2016
Conversion to is in progress
Conversion to is failed